These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Emerging Biomarkers in the Laboratory and in Practice: A Novel Approach to Diagnosing Heart Failure in Diabetes. Aaron RE; Tian T; Fleming GA; Sacks DB; Januzzi JL; Facc MD; Pop-Busui R; Hashim IA; Wu AHB; Pandey A; Klonoff DC J Diabetes Sci Technol; 2024 May; 18(3):733-740. PubMed ID: 38292004 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M J Card Fail; 2023 May; 29(5):787-804. PubMed ID: 37117140 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society. Tsutsui H; Albert NM; Coats AJS; Anker SD; Bayes-Genis A; Butler J; Chioncel O; Defilippi CR; Drazner MH; Felker GM; Filippatos G; Fiuzat M; Ide T; Januzzi JL; Kinugawa K; Kuwahara K; Matsue Y; Mentz RJ; Metra M; Pandey A; Rosano G; Saito Y; Sakata Y; Sato N; Seferovic PM; Teerlink J; Yamamoto K; Yoshimura M Eur J Heart Fail; 2023 May; 25(5):616-631. PubMed ID: 37098791 [TBL] [Abstract][Full Text] [Related]
5. Depressive symptoms in asymptomatic stage B heart failure with Type II diabetic mellitus. Mills PJ; Taub PR; Lunde O; Pung MA; Wilson K; Pruitt C; Rutledge T; Maisel A; Greenberg BH Clin Cardiol; 2019 Jun; 42(6):637-643. PubMed ID: 31017303 [TBL] [Abstract][Full Text] [Related]
6. SCReening Evaluation of the Evolution of New Heart Failure Study (SCREEN-HF): early detection of chronic heart failure in the workplace. Boffa U; McGrady M; Reid CM; Shiel L; Wolfe R; Liew D; Campbell DJ; Stewart S; Krum H Aust Health Rev; 2017 May; 41(2):121-126. PubMed ID: 27096227 [TBL] [Abstract][Full Text] [Related]
7. [Biomarkers for the diagnosis and management of heart failure: natriuretic peptides]. Castiglione V; Vergaro G; Aimo A; Prontera C; Musetti V; Masotti S; Battaglia D; Di Cecco P; Emdin M; Passino C G Ital Cardiol (Rome); 2021 Apr; 22(4):292-300. PubMed ID: 33783449 [TBL] [Abstract][Full Text] [Related]
8. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community. Xanthakis V; Enserro DM; Larson MG; Wollert KC; Januzzi JL; Levy D; Aragam J; Benjamin EJ; Cheng S; Wang TJ; Mitchell GF; Vasan RS JACC Heart Fail; 2016 Oct; 4(10):808-815. PubMed ID: 27395350 [TBL] [Abstract][Full Text] [Related]
9. Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure: A Health Technology Assessment. Ontario Health (Quality) Ont Health Technol Assess Ser; 2021; 21(2):1-125. PubMed ID: 34055110 [TBL] [Abstract][Full Text] [Related]
10. Reclassification of Pre-Heart Failure Stages Using Cardiac Biomarkers: The ARIC Study. Jia X; Al Rifai M; Ndumele CE; Virani SS; de Lemos JA; Lee E; Shah AM; Echouffo-Tcheugui JB; Bozkurt B; Hoogeveen R; Selvin E; Ballantyne CM; Nambi V JACC Heart Fail; 2023 Apr; 11(4):440-450. PubMed ID: 36881398 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of NT-proBNP-supported screening of chronic heart failure in patients with or without type 2 diabetes in Austria and Switzerland. Walter E; Arrigo M; Allerstorfer S; Marty P; Hülsmann M J Med Econ; 2023; 26(1):1287-1300. PubMed ID: 37781889 [TBL] [Abstract][Full Text] [Related]
12. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction. Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783 [TBL] [Abstract][Full Text] [Related]
13. Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology. Seferović P; Farmakis D; Bayes-Genis A; Ben Gal T; Böhm M; Chioncel O; Ferrari R; Filippatos G; Hill L; Jankowska E; Lainscak M; Lopatin Y; Lund LH; Mebazaa A; Metra M; Moura B; Rosano G; Thum T; Voors A; Coats AJS Eur J Heart Fail; 2022 Jul; 24(7):1162-1170. PubMed ID: 35703329 [TBL] [Abstract][Full Text] [Related]
14. High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs. Silver MA; Pisano C Congest Heart Fail; 2003; 9(3):127-32. PubMed ID: 12826770 [TBL] [Abstract][Full Text] [Related]
15. Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies. van Doorn S; Geersing GJ; Kievit RF; van Mourik Y; Bertens LC; van Riet EES; Boonman-de Winter LJ; Moons KGM; Hoes AW; Rutten FH Heart; 2018 Aug; 104(15):1236-1237. PubMed ID: 29549089 [TBL] [Abstract][Full Text] [Related]
16. Heart failure prevalence in the general population: SOBOTA-HF study rationale and design. Lainscak M; Omersa D; Sedlar N; Anker SD; Farkas J ESC Heart Fail; 2019 Oct; 6(5):1077-1084. PubMed ID: 31347289 [TBL] [Abstract][Full Text] [Related]
17. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations. Mueller C; McDonald K; de Boer RA; Maisel A; Cleland JGF; Kozhuharov N; Coats AJS; Metra M; Mebazaa A; Ruschitzka F; Lainscak M; Filippatos G; Seferovic PM; Meijers WC; Bayes-Genis A; Mueller T; Richards M; Januzzi JL; Eur J Heart Fail; 2019 Jun; 21(6):715-731. PubMed ID: 31222929 [TBL] [Abstract][Full Text] [Related]
18. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction. Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958 [TBL] [Abstract][Full Text] [Related]
19. Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure. Watson C; James S; O'Connell E; Gallagher J; O'Reilly J; Tallon E; Baugh J; O'Connell J; O'Shea D; Ledwidge M; McDonald K Biomarkers; 2016 Sep; 21(6):538-43. PubMed ID: 27049231 [TBL] [Abstract][Full Text] [Related]
20. The double burden: type 1 diabetes and heart failure-a comprehensive review. Julián MT; Pérez-Montes de Oca A; Julve J; Alonso N Cardiovasc Diabetol; 2024 Feb; 23(1):65. PubMed ID: 38347569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]